Clinical trial · Interventional
TICOP Mobile App and E-platform: Providing Information and Support for Parents Caring for Their Child Cancer Survivor
Digital Technology for Parents in Pediatric Oncology: Development and Implementation
NCT03945032CI-TRIAL-00072121TICOPwithdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): In process (technical improvements)
Summary
Brief summary (as posted)
This study aims to develop a mobile App (named "TICOP") for parents of a childhood cancer survivor and an E-Platform for health professionals which work in pediatric oncology area. The core objective is to evaluate the effects of these two digital tools (mobile app and platform) in the detection and prevention among parents of a childhood cancer survivor.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mobile Application | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| TICOP | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 8 parents of a childhood cancer survivor
- description
- Parent moves the cursor by analogy on their mobile phone (as a visual anagogic scale) four times per year (baseline; month 4; month 8 and month 12).
- interventionNames
- Other: TICOP
Primary outcomes (7)
- measure
- Psychological symptoms (created for the needs of the study)
- timeFrame
- Measure assessing change between four time points (change from Baseline at 4 months, 8 months and 12 months)
- description
- 13 items ranged between 0% at 100% \[Visual Analog Scale\] Scale range : 0 = rarely; 1 = occasionally ; 2 = often; 3 = mostly Note. Results are significant when the score is above 25% for one single item with at least two occurrences over time period.
- measure
- Psychosomatic symptoms (created for the needs of the study)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Parent of a childhood cancer survivor (mother and father) * Child who had been diagnosed in remission since 1 years until 10 years (without relapse) * Neoadjuvant chemotherapy during treatments * Fluency in French speaking * No previous evidence of mental illness. Exclusion Criteria: * Diagnosis of cancer treated only by surgery or radiotherapy (with no adjuvant chemotherapy) * Benign tumor * Child has a relapse or died * Non-French-speaking parents * previous evidence of mental illness.
References
Publications (3)
- BACKGROUNDVander Haegen M, Etienne AM. Intolerance of uncertainty in parents of childhood cancer survivors: A clinical profile analysis. J Psychosoc Oncol. 2018 Nov-Dec;36(6):717-733. doi: 10.1080/07347332.2018.1499692. Epub 2018 Nov 14. PMID 30427278
- BACKGROUNDVander Haegen M, Etienne AM. Intolerance of uncertainty as the vulnerability factor among parents of childhood cancer survivors: A 3-month follow-up study. J Psychosoc Oncol. 2018 Jul-Aug;36(4):437-453. doi: 10.1080/07347332.2018.1443192. Epub 2018 May 14. PMID 29757114
- BACKGROUNDVander Haegen M, Luminet O. Stress, Psychosocial Mediators, and Cognitive Mediators in Parents of Child Cancer Patients and Cancer Survivors: Attention and Working Memory Pathway Perspectives. J Psychosoc Oncol. 2015;33(5):504-50. doi: 10.1080/07347332.2015.1067279. PMID 26181302